![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PHARMING ANNOUNCES RESEARCH COLLABORATION
PHARMING ANNOUNCES RESEARCH COLLABORATION
July 13, 2005
Pharming Group ("Pharming" or "the Company") announced today a research collaboration with NovaThera ("NovaThera"). Pharming and NovaThera are to collaborate on combining NovaThera's proprietary biomaterial products with Pharming's recombinant proteins such as human collagen, fibrinogen, lactoferrin and C1 inhibitor. The collaboration takes advantage of the complementary capabilities of products from Pharming and Novathera and could provide Pharming with several new products.
PrimeZone Media Network (http://www.primezone.com/newsroom/news_releases.mhtml?d=81551)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct